The rheumatoid arthritis HLA-DRB1 shared epitope.
The rheumatoid arthritis HLA-DRB1 shared epitope.
复制标题
DOI:
10.1097/bor.0b013e328336ba63
复制
发表时间:
2010-05
影响因子:
5.1
通讯作者:
Holoshitz J
中科院分区:
文献类型:
--
作者:
Holoshitz J
To update progress made between December 2008 and November 2009 on the role of the rheumatoid arthritis (RA) shared epitope (SE) in the etiology and pathogenesis of RA. New evidence has been recently presented to suggest that non-inherited HLA antigens originating through pregnancy or exposure to maternal antigens in utero could contribute to RA development in SE-negative women. An interaction between smoking and SE-coding non-*04 HLA-DRB1 alleles (particularly HLA-DRB1*01 and HLA-DRB1*10) was formally established for the first time. Progress has been made in determining the relative contributions and the interaction of the SE, PTPN22 and smoking in conferring the risk of anti-citrullinated protein antibodies (ACPA)-positive and –negative RA. The autoantigen which ACPA recognize in a significant number of RA patients has been identified as citrullinated α enolase and the importance of genetic factors in ACPA-negative RA has been highlighted. Additionally, associations of RA risk with several new genetic markers have been reported. Among them: 2 new MHC, non-DRB1loci, a polymorphism marker in MHC class I polypeptide-related sequence A (MICA), an allele of the Fcγ receptor; a polymorphism marker in the β2 adrenergic receptor and a low-inducible allele of the cytochrome P450 subtype 1A2. While the mechanistic basis of SE-RA association remain an enigma, observations made during the last year shed new light on the conditions in which the SE - alone or in combination with other genes or environmental factors - affects the risk of RA and the phenotype of the disease.